Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 1.000 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.551 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.550 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.549 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.547 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.546 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.544 | |
2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.540 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.540 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.539 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.538 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.537 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.536 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.536 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.533 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.532 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.529 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.528 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.528 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.527 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.527 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.526 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.525 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.522 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.522 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.522 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.521 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.521 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.521 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.521 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.520 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.519 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.519 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.517 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.517 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.517 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.516 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.515 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.515 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.514 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.513 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.512 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.511 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.510 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.508 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.508 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.508 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.508 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.506 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.506 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.505 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.505 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.505 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.505 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.504 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.504 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.503 | |
2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.502 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.502 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.502 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.502 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.502 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.502 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.501 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.501 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.501 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.500 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.499 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.498 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.498 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.498 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.498 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.498 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.496 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.496 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.496 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.495 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.493 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.492 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.492 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.492 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.490 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.490 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.490 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.489 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.489 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.489 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.489 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.488 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.488 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.487 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.487 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.487 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.487 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.487 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.486 | |
4j98 | ACP | Fibroblast growth factor receptor 2 | / | 0.486 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.485 | |
4y95 | 746 | Tyrosine-protein kinase | / | 0.485 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.484 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.482 | |
1y6b | AAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.482 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.482 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.481 | |
2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.480 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.479 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.479 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.479 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
2hcd | BIV | Vitamin D3 receptor A | / | 0.478 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.478 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.478 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.478 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.477 | |
3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.477 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.477 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.477 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.477 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.476 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.476 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.476 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.476 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.476 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.476 | |
1fml | RTL | Retinol dehydratase | / | 0.475 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.475 | |
3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.475 | |
3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.475 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.475 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.474 | |
3qly | 55V | Uncharacterized protein | / | 0.474 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.474 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.474 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.474 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.474 | |
4wa9 | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.474 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.474 | |
2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
4ia3 | BIV | Vitamin D3 receptor A | / | 0.473 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.473 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.473 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.473 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.472 | |
3t8o | ATP | Rhodopsin kinase | / | 0.472 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.472 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.472 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.472 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.471 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.471 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.471 | |
1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.470 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.470 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.470 | |
3vrw | YS5 | Vitamin D3 receptor | / | 0.470 | |
4af3 | VX6 | Aurora kinase B | 2.7.11.1 | 0.470 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.470 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.470 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.470 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.469 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.469 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.469 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.469 | |
1syn | F89 | Thymidylate synthase | / | 0.468 | |
1y6a | AAZ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.468 | |
3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.468 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.468 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.468 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.467 | |
2lba | CHO | Fatty acid binding protein 6 | / | 0.467 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.467 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.467 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.467 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.467 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.467 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.467 | |
4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.467 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.466 | |
3irx | UDR | Gag-Pol polyprotein | 2.7.7.49 | 0.466 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.465 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.464 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.464 | |
4iui | 1GQ | Estrogen receptor | / | 0.464 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.464 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.464 | |
5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.464 | |
1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.463 | |
4ia1 | BIV | Vitamin D3 receptor A | / | 0.463 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.463 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.463 | |
1fmj | RTL | Retinol dehydratase | / | 0.462 | |
1j3k | WRA | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.462 | |
1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.462 | |
1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.462 | |
2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.462 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.462 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.462 | |
3uim | ANP | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 | 2.7.10.1 | 0.462 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.462 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.461 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.461 | |
2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.461 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.461 | |
4g1z | 0VP | Vitamin D3 receptor A | / | 0.461 | |
1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.460 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.460 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.460 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.460 | |
3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.460 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.460 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.460 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.460 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.460 | |
4rup | H97 | Vitamin D3 receptor A | / | 0.460 | |
2nq8 | ZID | Enoyl-ACP reductase | / | 0.459 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.459 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.458 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.458 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.458 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.458 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.458 | |
3ezp | B3N | Histone deacetylase 8 | 3.5.1.98 | 0.458 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.458 | |
4e37 | NDP | Catalase | 1.11.1.6 | 0.458 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.458 | |
4wbo | ANW | Rhodopsin kinase | / | 0.458 | |
1x8l | OXR | Retinol dehydratase | / | 0.457 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.457 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.457 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
3acj | KSS | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.457 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.457 | |
3t2y | FAD | Sulfide-quinone reductase | / | 0.457 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
2fzh | DH1 | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.456 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
4g1y | 0VO | Vitamin D3 receptor A | / | 0.456 | |
4nh8 | 2LC | Heat shock protein HSP 90-alpha | / | 0.456 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.455 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.455 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.454 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
2hzi | JIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.454 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.454 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.454 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.454 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.454 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.453 | |
1vrw | NAI | Enoyl-ACP reductase | / | 0.453 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.453 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.453 | |
3q5i | ANP | Protein kinase, putative | / | 0.453 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.453 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.453 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
4bb6 | HD1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.453 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.453 | |
1iyz | NDP | Probable quinone oxidoreductase | / | 0.452 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.452 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.452 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.452 | |
4aw5 | 30K | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.452 | |
1daj | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.451 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.451 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3vtc | TK3 | Vitamin D3 receptor | / | 0.451 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.451 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.451 | |
4jlk | 1NO | Deoxycytidine kinase | 2.7.1.74 | 0.451 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.451 | |
1dhj | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.450 | |
2hc4 | VDX | Vitamin D3 receptor A | / | 0.450 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.450 | |
3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.450 | |
3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.450 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.450 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.450 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.450 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.449 | |
2has | C3O | Vitamin D3 receptor | / | 0.449 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.449 | |
3uo5 | 0BX | Aurora kinase A | 2.7.11.1 | 0.449 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.449 | |
4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.449 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.449 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.449 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.449 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.449 | |
1eup | ASD | 6-deoxyerythronolide B hydroxylase | / | 0.448 | |
1rkh | VD2 | Vitamin D3 receptor | / | 0.448 | |
2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
2vwv | 7X3 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.448 | |
2w2l | NAD | D-mandelate dehydrogenase | / | 0.448 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.448 | |
3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.448 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
4h97 | 53S | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.448 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.448 | |
1drb | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
1txi | TX5 | Vitamin D3 receptor | / | 0.447 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.447 | |
3jsu | KA5 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.447 | |
3kpz | ZNE | Vitamin D3 receptor | / | 0.447 | |
3p3e | 3P3 | UDP-3-O-acyl-N-acetylglucosamine deacetylase | / | 0.447 | |
3w5t | LHP | Vitamin D3 receptor | / | 0.447 | |
1j3i | WRA | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.446 | |
2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
2oyu | IMS | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.446 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.446 | |
3sz0 | FAD | Sulfide-quinone reductase | / | 0.446 | |
3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.446 | |
3um5 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.446 | |
3vt5 | YI2 | Vitamin D3 receptor | / | 0.446 | |
4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.446 | |
4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.446 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.446 | |
4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.446 | |
4ruo | BIV | Vitamin D3 receptor A | / | 0.446 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
1m13 | HYF | Nuclear receptor subfamily 1 group I member 2 | / | 0.445 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.445 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.445 | |
3is9 | AC7 | Gag-Pol polyprotein | 2.7.7.49 | 0.445 | |
3och | 2MX | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
3w5r | LOA | Vitamin D3 receptor | / | 0.445 | |
4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.445 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.445 | |
1nhz | 486 | Glucocorticoid receptor | / | 0.444 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2y30 | SM8 | Putative repressor SimReg2 | / | 0.444 | |
3sls | 77D | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.444 | |
3v2u | ATP | Protein GAL3 | / | 0.444 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.444 | |
4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
4h95 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
1m7a | MQU | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.443 | |
2bel | CBO | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.443 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.443 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.443 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.443 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
3cx5 | SMA | Cytochrome b | / | 0.443 | |
3drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.443 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.443 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.443 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4ia2 | BIV | Vitamin D3 receptor A | / | 0.443 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.443 | |
4ly9 | 1YY | Glucokinase regulatory protein | / | 0.443 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.443 | |
4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.443 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.442 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3h3s | H15 | Collagen type IV alpha-3-binding protein | / | 0.442 | |
3lak | KR1 | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
3vso | EK1 | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.442 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.442 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.442 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.442 | |
1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.441 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.441 | |
2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.441 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.441 | |
3ddw | 055 | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.441 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
3vt6 | 5YI | Vitamin D3 receptor | / | 0.441 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.441 | |
3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.441 | |
4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.441 | |
4i6g | FAD | Cryptochrome-2 | / | 0.441 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.441 | |
4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.441 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.441 | |
4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.441 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.441 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
1dkf | BMS | Retinoic acid receptor alpha | / | 0.440 | |
1klk | PMD | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1l2j | ETC | Estrogen receptor beta | / | 0.440 | |
2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.440 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.440 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.440 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.440 | |
3w0j | T08 | Vitamin D3 receptor | / | 0.440 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
5akk | 1P8 | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.440 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 |